PriceTargets.com logo

Everus - ECG Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $67.67
  • Forecasted Upside: 0.86%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$67.09 As of 12/20/2024 06:40 PM ET
▲ +2.49 (3.85%)

This chart shows the closing price for ECG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Everus Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ECG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ECG

Analyst Price Target is $67.67
▲ +0.86% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Everus in the last 3 months. The average price target is $67.67, with a high forecast of $78.00 and a low forecast of $55.00. The average price target represents a 0.86% upside from the last price of $67.09.

This chart shows the closing price for ECG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 4 contributing investment analysts is to moderate buy stock in Everus.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/27/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/22/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
11/21/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
12/21/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/11/2024Stifel NicolausBoost TargetBuy ➝ Buy$71.00 ➝ $78.00
12/4/2024OppenheimerInitiated CoverageOutperform$70.00
12/3/2024Wolfe ResearchInitiated CoveragePeer Perform
11/15/2024Stifel NicolausInitiated CoverageBuy$71.00
11/4/2024DA DavidsonInitiated CoverageNeutral$55.00
(Data available from 12/21/2019 forward)

News Sentiment Rating

0.08 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/25/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/24/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/24/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/23/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2024
  • 0 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2024
  • 0 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2024

Current Sentiment

  • 0 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Everus logo
Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers. Everus Construction Group is based in BISMARCK, N.D.
Read More

Today's Range

Now: $67.09
Low: $62.56
High: $67.39

50 Day Range

MA: N/A

52 Week Range

Now: $67.09
Low: $40.05
High: $71.42

Volume

1,509,178 shs

Average Volume

718,244 shs

Market Capitalization

$3.42 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Everus?

The following sell-side analysts have issued research reports on Everus in the last year: DA Davidson, Oppenheimer Holdings Inc., Stifel Nicolaus, and Wolfe Research.
View the latest analyst ratings for ECG.

What is the current price target for Everus?

0 Wall Street analysts have set twelve-month price targets for Everus in the last year. Their average twelve-month price target is $67.67, suggesting a possible upside of 0.9%. Stifel Nicolaus has the highest price target set, predicting ECG will reach $78.00 in the next twelve months. DA Davidson has the lowest price target set, forecasting a price of $55.00 for Everus in the next year.
View the latest price targets for ECG.

What is the current consensus analyst rating for Everus?

Everus currently has 2 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for ECG.

What other companies compete with Everus?

Other companies that are similar to Everus include Toll Brothers, Taylor Morrison Home, Meritage Homes, KB Home and M/I Homes. Learn More about companies similar to Everus.

How do I contact Everus' investor relations team?

The company's listed phone number is 701-221-6400 and its investor relations email address is [email protected]. The official website for Everus is everus.com. Learn More about contacing Everus investor relations.